PubIndex
Search
Leaderboards
Bookmark
My Library
Sign in
Back
Cell Signaling Technology
Rapamycin
#9904 · $90
100
Citing papers
4.7k
Combined citations
Copy product info
Export PDF dossier
Supplier page
Find this product
Research areas
Autophagy in Disease and Therapy
11
PI3K/AKT/mTOR signaling in cancer
6
Angiogenesis and VEGF in Cancer
6
Berberine and alkaloids research
6
Immunotherapy and Immune Responses
5
Adipose Tissue and Metabolism
5
Neuroscience and Neuropharmacology Research
5
Cytomegalovirus and herpesvirus research
4
Papers citing this product
1
Axonal Protein Synthesis and Degradation Are Necessary for Efficient Growth Cone Regeneration
Journal of Neuroscience
·
2005
·
412 cit.
·
DOI
2
Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance
Oncogene
·
2015
·
248 cit.
·
DOI
3
Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK–STAT pathway in Sézary syndrome
Nature Communications
·
2015
·
202 cit.
·
DOI
4
The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching
The Journal of Cell Biology
·
2008
·
177 cit.
·
DOI
5
Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington’s disease knock-in striatal cells
Free Radical Biology and Medicine
·
2014
·
138 cit.
·
DOI
6
FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance
Oncogene
·
2013
·
133 cit.
·
DOI
7
Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming
Journal of Experimental & Clinical Cancer Research
·
2022
·
122 cit.
·
DOI
8
Striatal Dysfunctions Associated with Mitochondrial DNA Damage in Dopaminergic Neurons in a Mouse Model of Parkinson's Disease
Journal of Neuroscience
·
2011
·
120 cit.
·
DOI
9
The Striatum Is Highly Susceptible to Mitochondrial Oxidative Phosphorylation Dysfunctions
Journal of Neuroscience
·
2011
·
114 cit.
·
DOI
10
In situ generation of micrometer-sized tumor cell-derived vesicles as autologous cancer vaccines for boosting systemic immune responses
Nature Communications
·
2022
·
110 cit.
·
DOI
Show 90 more papers
Feedback